Mechanisms of particulate chromium lung carcinogenesis

颗粒铬肺癌发生机制

基本信息

  • 批准号:
    7990590
  • 负责人:
  • 金额:
    $ 23.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-09 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Certain chromium compounds are well-established human respiratory toxins and carcinogens. Major environmental health concerns stem from the deposition of chromium in industrial waste either in the form of dissolved chromate compounds released to surface waters or chromate slag used in landfills. Chromium is generated as an atmospheric pollutant during ferrochrome production, ore refining, welding, and incinerations of all types. Hexavalent chromate, Cr(VI), is currently one of 33 compounds listed by the Environmental Protection Agency (EPA) to pose the greatest potential health threat in urban areas and chromate compounds are listed by NIOSH (National Institute of Occupational Safety and Health) to be one of the major causes of occupational lung cancer. While considerable information exists regarding Cr(VI) genotoxicity in cell culture, the mechanisms by which Cr(VI) causes lung injury and carcinogenesis in vivo are still unknown. A major drawback has been the lack of a suitable animal model that reproduces the lung tissue microenvironment induced by chromium exposure in humans. One critical question is why Cr(VI), shown to be one of the most potent genotoxic agents in occupational and environmental settings, fails to induce carcinogenesis in experimental animals except in very select cases. We propose that most animal models fail to induce tumor development in response to inhaled Cr(VI) because they are missing a key contributing factor: the appropriate type of chronic tissue inflammation. Thus, the goal of our proposed studies is to directly test the contribution of inflammatory processes to chromate-mediated lung cancer development, using a new mouse model of Cr(VI) respiratory exposure that includes chronic lung tissue inflammatory responses. For our proposed studies we will use the BALB/c mouse model for intranasal delivery of hexavalent basic zinc chromate (ZnCrO44Zn(OH)2), which is an intermediately water soluble chromate typically encountered in mining and chromate production facilities and is also present as an environmental atmospheric contaminant in urban areas surrounding ferrochrome production facilities. The following two working hypotheses will be tested: 1) Cr(VI)-mediated oncogenesis is associated with sequential changes in tissue inflammation, injury/repair and cell survival dysregulation; 2) Inflammatory processes are required for the neoplastic events that lead to lung tumor generation by Cr(VI) exposure. Our long-term goal is to establish a non-human model of Cr(VI) exposure that can be used to dissect the mechanism whereby inhaled Cr(VI) induces lung cancer. Results from these studies will have the added benefit of identifying molecular targets for potential interventional or preventive therapy. An important aspect of the significance of the proposed studies is the use of an occupationally and environmentally relevant form of particulate Cr(VI), as a pure compound, with a delivery system which mimics human exposure. The findings will also be relevant to other lung particulates that induce injury and cancer. PUBLIC HEALTH RELEVANCE: Certain particulate chromium compounds are well established atmospheric pollutants and human respiratory toxins and carcinogens, while environmental and occupational exposure to chromate continues to loom large as a major public health issue. This proposal will employ a new mouse model that reproduces the lung tissue microenvironment induced by chromium exposure in humans. The proposed studies will provide valuable new insights into the complex etiology of the disease process, as well as provide a means to evaluate the contribution of the inflammatory environment and survival signaling pathways to chromium carcinogenesis.
描述(由申请人提供):某些铬化合物是公认的人类呼吸道毒素和致癌物。主要的环境健康问题源于工业废物中铬的沉积,要么以溶解的铬酸盐化合物的形式释放到地表水中,要么以垃圾填埋场使用的铬酸盐渣的形式存在。铬是在各种类型的铬铁生产、矿石精炼、焊接和焚烧过程中产生的大气污染物。六价铬酸盐 (Cr(VI)) 目前是美国环境保护署 (EPA) 列出的对城市地区构成最大潜在健康威胁的 33 种化合物之一,并且 NIOSH(美国国家职业安全与健康研究所)将铬酸盐化合物列为对城市地区构成最大潜在健康威胁的 33 种化合物之一。是职业性肺癌的主要原因之一。虽然关于细胞培养中 Cr(VI) 基因毒性的大量信息存在,但 Cr(VI) 在体内引起肺损伤和致癌的机制仍不清楚。主要缺点是缺乏合适的动物模型来重现人类铬暴露引起的肺组织微环境。一个关键问题是,为什么六价铬(Cr(VI))被证明是职业和环境环境中最有效的基因毒性剂之一,除了极少数情况外,却无法在实验动物中诱发致癌作用。我们认为,大多数动物模型未能通过吸入 Cr(VI) 诱导肿瘤发展,因为它们缺少一个关键的影响因素:适当类型的慢性组织炎症。因此,我们提出的研究的目标是使用包括慢性肺组织炎症反应的新的六价铬呼吸暴露小鼠模型,直接测试炎症过程对铬酸盐介导的肺癌发展的贡献。对于我们提出的研究,我们将使用 BALB/c 小鼠模型鼻内输送六价碱性铬酸锌 (ZnCrO44Zn(OH)2),它是一种中等水溶性的铬酸盐,通常在采矿和铬酸盐生产设施中遇到,也作为一种铬铁生产设施周围城市地区的环境大气污染物。将测试以下两个工作假设:1)Cr(VI)介导的肿瘤发生与组织炎症、损伤/修复和细胞存活失调的连续变化有关; 2) 因接触 Cr(VI) 而导致肺部肿瘤生成的肿瘤事件需要炎症过程。我们的长期目标是建立一个非人类的 Cr(VI) 暴露模型,可用于剖析吸入 Cr(VI) 诱发肺癌的机制。这些研究的结果将具有确定潜在介入或预防性治疗的分子靶点的额外好处。拟议研究的一个重要方面是使用与职业和环境相关的颗粒 Cr(VI),作为纯化合物,并具有模拟人类暴露的输送系统。这些发现也与其他引起损伤和癌症的肺部颗粒物有关。 公共卫生相关性:某些颗粒铬化合物是公认的大气污染物、人类呼吸道毒素和致癌物,而环境和职业接触铬酸盐仍然是一个重大的公共卫生问题。该提案将采用一种新的小鼠模型,该模型可以重现人类因铬暴露而引起的肺组织微环境。拟议的研究将为疾病过程的复杂病因学提供有价值的新见解,并提供一种评估炎症环境和生存信号通路对铬致癌作用的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN M CERYAK其他文献

SUSAN M CERYAK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN M CERYAK', 18)}}的其他基金

Mechanisms of particulate chromium lung carcinogenesis
颗粒铬肺癌发生机制
  • 批准号:
    8125032
  • 财政年份:
    2010
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    7339973
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    6867502
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    7545876
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    7162609
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    7545032
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    7285057
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    7001305
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    7746024
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:
Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
  • 批准号:
    7324802
  • 财政年份:
    2005
  • 资助金额:
    $ 23.48万
  • 项目类别:

相似国自然基金

髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
  • 批准号:
    82372496
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
  • 批准号:
    82270081
  • 批准年份:
    2022
  • 资助金额:
    76 万元
  • 项目类别:
    面上项目
脆性X综合征动物模型中异常视觉信息处理和视觉注意力的神经环路机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目

相似海外基金

Speckle x-ray imaging: detecting early changes in lung microstructure
散斑 X 射线成像:检测肺微结构的早期变化
  • 批准号:
    10560958
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
  • 批准号:
    10658610
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
Aerosol Ventilation for Rapid Cooling of Transplant Donor Lungs
用于快速冷却移植供体肺的气雾通气
  • 批准号:
    10481907
  • 财政年份:
    2022
  • 资助金额:
    $ 23.48万
  • 项目类别:
Modeling pulmonary fibrosis progression caused by differential mechanical stretch
模拟差异机械拉伸引起的肺纤维化进展
  • 批准号:
    10677845
  • 财政年份:
    2022
  • 资助金额:
    $ 23.48万
  • 项目类别:
Preclinical development of a synthetic lung surfactant dry powder aerosol for acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
  • 批准号:
    10704308
  • 财政年份:
    2022
  • 资助金额:
    $ 23.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了